Recently， the cardiovascular disease has been widely problematic in humans probably due to fibrin formation via the unbalanced Western style diet. Although direct (human plasmin) and indirect methods (plasminogen activators) have been available， bacterial enzyme methods have been studied because of their cheap and mass production. To detect a novel bacterial fibrinolytic enzyme， 111 bacterial strains with fibrinolytic activity were selected from kimchi. Among them， 14 strains were selected because of their stronger activity than 0.02 U of plasmin. Their 16S rRNA sequence analysis revealed that they belong to Bacillus， Leuconostoc， Propionibacterium， Weissella， Staphylococcus， and Bifidobacterium. The strain B. subtilis ZA400， with the highest fibrinolytic activity， was selected and the gene encoding fibrinolytic enzyme (bsfA) was cloned and expressed in the E. coli overexpression system. The purified enzyme was analyzed with SDS-PAGE， western blot， and MALDI-TOF analyses， showing to be 28.4 kDa. Subsequently， the BsfA was characterized to be stable under various stress conditions such as temperature (4-40°C)， metal ions (Mn(2+)， Ca(2+)， K(2+)， and Mg(2+))， and inhibitors (EDTA and SDS)， suggesting that BsfA could be a good candidate for development of a novel fibrinolytic enzyme for thrombosis treatment and may even be useful as a new bacterial starter for manufacturing functional fermented foods.